AS of ANXA7, MARK4, MAX, USP5, WWOX, BIN, RON, and CCND1 were reported to affect critical biological functions of glioma, resulting in altered prognosis [13–15]; however, a systematic analysis of glioma splicing profiles has not been performed. This evidence concerns the gene ANXA7 and central nervous system cancer.